» Articles » PMID: 21310086

Physician Attitudes and Treatment Patterns for Pancreatic Cancer

Overview
Publisher Biomed Central
Date 2011 Feb 12
PMID 21310086
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgery appears to be an underutilized treatment option for pancreatic cancer. Nihilistic physician attitudes may be partly responsible. The study objectives were to analyze physician attitudes towards this disease and determine treatment patterns and outcomes including rates of surgical referral.

Methods: A survey was administered to 420 physicians in Manitoba to document general knowledge and attitudes. Population based administrative data was accessed for all patients diagnosed with pancreatic cancer between 2004 and 2006 to examine treatment patterns and outcomes.

Results: 181 physicians responded to the survey. Most (73%) believed that surgical resection was worthwhile. Of the 413 Manitobans diagnosed with pancreatic cancer, only 11% underwent an attempt at surgical resection. There were 124 patients with stage I or II disease (i.e. potentially resectable), 85 of these patients received no treatment and 39% were not referred to a surgeon. These patients were older than those referred, but did not have more comorbidities.

Conclusion: Most physicians were insightfully aware of both the survival benefit and potential risks of surgical resection. However, some did overestimate the surgical mortality and underestimate the associated survival benefit. Although advanced age may justly account for some of the patients not receiving a referral, it is reasonable to assume that nihilistic physician attitudes is contributing to the apparent underutilization of surgery for pancreatic cancer. Efforts should be made to ensure that eligible patients are at least offered surgery as a potential treatment option.

Citing Articles

Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer.

Ejie J, Ganjouei A, Hernandez S, Wang J, Romero-Hernandez F, Foroutani L Cancers (Basel). 2025; 17(2).

PMID: 39857951 PMC: 11763659. DOI: 10.3390/cancers17020170.


Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, Brazil.

de Jesus V, da Costa Jr W, Claro L, Coimbra F, Dettino A, Riechelmann R Sci Rep. 2021; 11(1):6346.

PMID: 33737639 PMC: 7973503. DOI: 10.1038/s41598-021-85759-5.


Neuropilin1 silencing impairs the proliferation and migration of cells in pancreatic cancer.

He L, He Y, Zuo W, Kang Y, Xue H, Wang L J Clin Lab Anal. 2020; 34(9):e23394.

PMID: 32472711 PMC: 7521280. DOI: 10.1002/jcla.23394.


Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.

Sun H, Wang H, Shi L, Wang M, Li J, Shi J BMJ Open. 2020; 10(2):e032336.

PMID: 32051302 PMC: 7045216. DOI: 10.1136/bmjopen-2019-032336.


Diagnosis and management of pancreatic cancer.

Kanji Z, Gallinger S CMAJ. 2013; 185(14):1219-26.

PMID: 23610017 PMC: 3787168. DOI: 10.1503/cmaj.121368.


References
1.
Bilimoria K, Bentrem D, Ko C, Stewart A, Winchester D, Talamonti M . National failure to operate on early stage pancreatic cancer. Ann Surg. 2007; 246(2):173-80. PMC: 1933550. DOI: 10.1097/SLA.0b013e3180691579. View

2.
Abrams R, Lowy A, OReilly E, Wolff R, Picozzi V, Pisters P . Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009; 16(7):1751-6. DOI: 10.1245/s10434-009-0413-9. View

3.
Yeo C, Sohn T, Cameron J, Hruban R, Lillemoe K, Pitt H . Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998; 227(6):821-31. PMC: 1191384. DOI: 10.1097/00000658-199806000-00005. View

4.
Crist D, Sitzmann J, Cameron J . Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987; 206(3):358-65. PMC: 1493175. DOI: 10.1097/00000658-198709000-00014. View

5.
Birkmeyer J, Stukel T, Siewers A, Goodney P, Wennberg D, Lucas F . Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349(22):2117-27. DOI: 10.1056/NEJMsa035205. View